LSE:AZN
LSE:AZNPharmaceuticals

Assessing AstraZeneca’s Value After Recent Pipeline Developments and Strategic Partnerships

Curious if AstraZeneca is actually a bargain, or if the share price is already factoring in all the good news? Many investors wonder whether now is the right moment to get in or take profits, and we’re about to break it down together. Despite some short-term wobbles, with the stock down 0.5% in the last week and -1.4% for the month, AstraZeneca’s stock has still returned 17.3% year-to-date and 65.0% over the last five years. Recent headlines have emphasized AstraZeneca’s ongoing pipeline...
LSE:BP.
LSE:BP.Oil and Gas

BP (LSE:BP.) Valuation in Focus After Recent Share Price Momentum and Earnings Updates

BP (LSE:BP.) shares have edged slightly lower today, even as the wider energy sector remains steady. Investors appear to be weighing up recent results and considering the group’s long-term growth outlook with a focus on the latest earnings. See our latest analysis for BP. BP’s share price has picked up notable momentum in recent months, up over 10% for the past quarter and nearly 10% year-to-date. The latest price moves have come after a series of upbeat earnings and solid sector performance...